Investor discloses 7.5% Catheter Precision (VTAK) stake in Schedule 13G

Rhea-AI Filing Summary

Catheter Precision, Inc. investor Joseph Reda filed a Schedule 13G reporting a significant ownership position in the company’s common stock. He beneficially owns 176,674 shares, representing 7.5% of the outstanding common stock, with sole voting and dispositive power over all these shares.

The 7.5% figure is based on 2,357,127 Catheter Precision common shares outstanding as verified with the issuer on February 11, 2026. Reda certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of Catheter Precision.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Catheter Precision, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

74933X708

(CUSIP Number)

02/06/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 74933X708

1

Names of Reporting Persons

Joseph Reda

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 176,674.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 176,674.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

176,674.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.5 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) Based on 2,357,127 shares of Common Stock of the Issuer outstanding as verified with the Issuer on February 11, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Catheter Precision, Inc.
(b)	Address of issuer's principal executive offices: 1670 Highway 160 West Fort Mill, SC 29708
Item 2.
(a)	Name of person filing: Joseph Reda
(b)	Address or principal business office or, if none, residence: 1324 Manor Circle Pelham, NY 10803
(c)	Citizenship: Joseph Reda is a citizen of the United States.
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 74933X708
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Item 9 on the cover pages(s) hereto.
(b)	Percent of class: See Item 11 on the cover page(s) hereto.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Item 5 on the cover pages hereto.
	(ii) Shared power to vote or to direct the vote: See Item 6 on the cover pages hereto.
	(iii) Sole power to dispose or to direct the disposition of: See Item 7 on the cover pages hereto.
	(iv) Shared power to dispose or to direct the disposition of: See Item 8 on the cover pages hereto.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Joseph Reda

Signature:	/s/ Joseph Reda
Name/Title:	Joseph Reda
Date:	02/11/2026

FAQ

What ownership stake in Catheter Precision (VTAK) does Joseph Reda report?

Joseph Reda reports beneficial ownership of 176,674 shares of Catheter Precision common stock, representing 7.5% of the outstanding class. He has sole voting and sole dispositive power over all these shares, indicating direct control over how they are voted and potentially sold.

How was Joseph Reda’s 7.5% ownership in Catheter Precision (VTAK) calculated?

The 7.5% ownership is based on 2,357,127 Catheter Precision common shares outstanding, as verified with the issuer on February 11, 2026. Reda’s 176,674 shares are measured against this total share count to determine his percentage of the company’s common stock.

Does Joseph Reda seek to influence control of Catheter Precision (VTAK)?

Joseph Reda certifies that his Catheter Precision shares were not acquired and are not held to change or influence control of the company. He also states they are not held in connection with any transaction having that purpose, other than activities related to a specific nomination rule.

What type of SEC filing did Joseph Reda submit for Catheter Precision (VTAK)?

Joseph Reda submitted a Schedule 13G, which is used to report beneficial ownership of more than 5% of a company’s registered equity securities. This filing discloses his share count, ownership percentage, and his representation regarding non-control intent toward Catheter Precision.

What voting and dispositive powers does Joseph Reda report over Catheter Precision (VTAK) shares?

Joseph Reda reports sole voting power and sole dispositive power over 176,674 Catheter Precision common shares and no shared powers. This means he alone can decide how these shares are voted and whether, when, and how they may be sold or otherwise disposed of.

When did the ownership event triggering this Schedule 13G for Catheter Precision (VTAK) occur?

The date of the event requiring this Schedule 13G filing is February 6, 2026. This date reflects when Joseph Reda’s ownership position reached the reportable level that triggered the obligation to disclose his beneficial holdings in Catheter Precision’s common stock.